Bristol-Myers Squibb’s Recent >$20bn M&A Spree Should Reward Patient Investors (NYSE:BMY)

Zerbor/iStock via Getty Images Investment Overview Bristol-Myers Squibb Company (NYSE:BMY), the Princeton, New Jersey-based Big Pharma concern, experienced a poor year in terms of share price performance in 2023. BMY is currently the seventh largest of the “Big 8” U.S.-headquartered global Pharmas, with a market cap of ~$107bn at the time of writing. Eli Lilly…

Read More

Armada Hoffler: This Could Be A Buying Opportunity But Only For Patient Investors (NYSE:AHH)

Helena GH/iStock via Getty Images Armada Hoffler Properties (NYSE:AHH) is a vertically integrated REIT that owns and operates a variety of real estate assets in southern half of east coast that include mixed-use, retail, multi-familiy residence and office properties. The company also has a side business that consists of offering services related to construction and…

Read More